Masaru Matsuda, See Remarks at Arcutis Biotherapeutics, Inc. (ARQT), sold 48,621 shares at $25.50 ($1.2M) on 2026-02-02, disclosed to the SEC on 2026-02-04.
Open-market sale of $1.2M ARQT by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.97 | 8,562 | $214K | 17.4% |
| 2 | $25.24 | 19,379 | $489K | 39.7% |
| 3 | $25.50 | 7,983 | $204K | 16.5% |
| 4 | $25.50 | 7,983 | $204K | 16.5% |
| 5 | $25.63 | 4,714 | $121K | 9.8% |
| Total | $25.32 avg | 48,621 |
| $1.2M |
| 100% |
| Filing → |
| ARQT | SELL | 2026-08-05 | $32K | — | Filing → |
| ARQT | SELL | 2026-05-06 | $192K | — | Filing → |
| ARQT | SELL | 2026-03-03 | $314K | — | Filing → |